MSD Animal Health, a division of Merck & Co., announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for €1...
11.06.2020
- Elanco has secured EU antitrust clearance for its planned $7.6 billion purchase of Bayer's veterinary drugs business after agreeing to sell some product lines to address the...
12.12.2019
- Bayer’s planned sale of its animal health business to Eli Lilly’s veterinary spinoff Elanco in a $7.6 billion cash and stock deal, sealed in August this year, now faces a delay...
21.08.2019
- As widely expected, Bayer has definitively agreed to sell its animal health business to Eli Lilly spinoff Elanco Animal Health. The $7.6 billion deal will create the market’s...
18.07.2019
- Pharmaceutical market buzz last month had it that private equity investors in Europe and the US were lining up to buy the animal health business Bayer is preparing for sale to pare...
29.07.2018
- Eli Lilly has announced plans to spin off its Elanco animal health business, ending months of uncertainty. The US drugmaker said it will file a registration in the coming weeks...
23.04.2014
- In one of several deals announced just after Easter, Swiss drugmaker Novartis said it would sell its animal health arm to U.S. rival Eli Lilly for about $5.4 billion. Lilly said...
